ACCURATE Trial - Operative Treatment of Acute Rotator Cuff Tear Related to Trauma
NCT ID: NCT02885714
Last Updated: 2025-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
180 participants
INTERVENTIONAL
2016-12-31
2025-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
During few last decades, despite the lack of evidence on the superiority of one treatment over another, the use of surgery to treat this disorder has been substantially increased. Treatment expectations are found to be important in predicting patient related outcome measures. In addition, surgery itself may produce a profound placebo effect. There are no previous placebo-controlled trials on the topic of interest. In order to find out the true efficacy of surgical treatment of acute, trauma related rotator cuff tears involving mainly the supraspinatus tendon, the investigators have designed this multi-centre, randomized, placebo-controlled efficacy trial.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Small Acute Cuff Tears, a Randomized Study
NCT02059473
Prosthesis Versus Active Exercise Program in Patients With Rotator Cuff Arthropathy
NCT04864158
Effect of Muscle Coactivation Strengthening for Rotator Cuff Tendinopathy
NCT02837848
Outcomes After Repair of Acute Rotator Cuff Tears
NCT01140230
Enhanced Function and Quality of Life Following 5 Months of Exercise Therapy for Patients With Rotator Cuff Tears
NCT02740946
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I
Placebo surgery + supervised specific exercises
Placebo surgery and supervised specific exercises
The patient is prepared for surgery as normal (plexus+general anesthesia or TIVA, with antibiotic prophylaxis). The arthroscope is introduced in the glenohumeral joint, and thereafter online randomization is performed. The joint space is evaluated. Nothing is to be removed or excised and the use of any vapour or shaver device is not allowed. The presence of a full-thickness rotator cuff tear is verified. Altogether 3 to 5 small stab wounds are made in typical locations resembling locations of typical rotator cuff repair. The time spent in the operating theatre with patients in placebo group should resemble the time spent with patients in the active treatment group and hence give an impression of a rotator cuff repair.
Group II
Rotator cuff repair + supervised specific exercises
Rotator cuff repair and supervised specific exercises
The patient is prepared for surgery as normal (plexus+general anesthesia or TIVA, with antibiotic prophylaxis). The arthroscope is introduced in the glenohumeral joint, and thereafter online randomization is performed. The joint space is evaluated and the presence of a full-thickness rotator cuff tear is verified. The cuff tear is repaired to its anatomic location using suture anchors according to surgeon preference. . A biceps tenotomy or tenodesis may be performed according to surgeon preference if the biceps tendon is noted to be frayed, unstable or inflamed. An additional acromioplasty may be performed according to surgeon preference.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo surgery and supervised specific exercises
The patient is prepared for surgery as normal (plexus+general anesthesia or TIVA, with antibiotic prophylaxis). The arthroscope is introduced in the glenohumeral joint, and thereafter online randomization is performed. The joint space is evaluated. Nothing is to be removed or excised and the use of any vapour or shaver device is not allowed. The presence of a full-thickness rotator cuff tear is verified. Altogether 3 to 5 small stab wounds are made in typical locations resembling locations of typical rotator cuff repair. The time spent in the operating theatre with patients in placebo group should resemble the time spent with patients in the active treatment group and hence give an impression of a rotator cuff repair.
Rotator cuff repair and supervised specific exercises
The patient is prepared for surgery as normal (plexus+general anesthesia or TIVA, with antibiotic prophylaxis). The arthroscope is introduced in the glenohumeral joint, and thereafter online randomization is performed. The joint space is evaluated and the presence of a full-thickness rotator cuff tear is verified. The cuff tear is repaired to its anatomic location using suture anchors according to surgeon preference. . A biceps tenotomy or tenodesis may be performed according to surgeon preference if the biceps tendon is noted to be frayed, unstable or inflamed. An additional acromioplasty may be performed according to surgeon preference.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Acute onset of shoulder symptoms after a traumatic event (any kind of sudden stretch, pull, fall, or impact, on the shoulder that is associated with the onset of symptoms)
3. Shoulder symptoms relating to rotator cuff tear = pain laterally on the shoulder and/or painful motion arc during abduction or flexion
4. MRI documented full thickness supraspinatus (ssp) tear
Exclusion Criteria
2. A delay of more than 4 months after the onset of symptoms of trauma to the day of intervention
3. Arthroscopically documented partial thickness rotator cuff tear only
4. A large MRI documented full thickness rotator cuff tear, sagittal tear size at the level of footprint larger than 3cm
5. MRI or arthroscopically documented total width of infraspinatus (isp) or subscapularis (ssc) tear
6. MRI or arthroscopically documented fully dislocated biceps tendon (biceps out of the groove) with concomitant subscapularis tear
7. Positive clinical rotatory lag sign (ER1 lag (\>10 degrees), lift off lag (involuntary drop against the back), horn blower lag (involuntary internal rotation of the forearm in supported elevated position))
8. Marked fatty degeneration in any of the cuff muscles (more than Fuchs/Goutallier grade 2)
9. Radiographically or MRI documented concomitant fracture line of the involved extremity or bony avulsion of the torn tendon or dislocation of the humeral head or the acromioclavicular joint.
10. Concomitant clinically detectable motoric nerve injury affecting the shoulder
11. Radiographically documented severe osteoarthritis of the glenohumeral joint, Samilson-Prieto 2 or above
12. Non-congruency of the glenohumeral joint in radiographs (Hamada stage 2 or above)
13. Clinical stiffness of the glenohumeral joint (severely limited passive range of motion: glenohumeral external rotation \< 30 degrees, and abduction with stabilized scapula \<60 degrees)
14. Previous surgery of the affected shoulder (affecting clavicle, scapula or upper third of the humerus)
15. Earlier sonographic or MRI finding of a rotator cuff tear
16. Previous symptoms of the ipsilateral shoulder requiring conservative treatment (glucocorticosteroid injections and/or physiotherapy) delivered by health care professionals during the last five years
17. Systemic glucocorticosteroid or antimetabolite medication during the last 5 years
18. Ongoing treatment for malignancy
19. ASA classification 3 or 4
20. Patient's inability to understand written and spoken Finnish, Norwegian or Swedish
21. History of alcoholism, drug abuse, psychological or other emotional problems likely to jeopardise informed consent
22. Patients with a contraindication/noncomplience for MRI examination or use of electrocautery devices
23. Previous randomization of the contralateral shoulder into the ACCURATE trial
24. Patient's denial for operative treatment and/or participation in the trial
45 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Turku University Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juha Kukkonen, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Satakunta Central Hospital
Anssi Ryösä, MD
Role: STUDY_CHAIR
Turku University Hospital
Hanna Björnsson Hallgren, MD, PhD
Role: STUDY_CHAIR
University Hospital, Linkoeping
Stefan Moosmayer, MD, PhD
Role: STUDY_CHAIR
Martina Hansens Hospital
Teresa Holmgren, PT, PhD
Role: STUDY_CHAIR
University Hospital, Linkoeping
Mats Ranebo, MD
Role: STUDY_CHAIR
Kalmar County Hospital
Berte Bøe, MD, PhD
Role: STUDY_CHAIR
Oslo University Hospital
Ville Äärimaa, Adj.Prof.
Role: STUDY_DIRECTOR
Turku University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helsinki University Hospital
Helsinki, , Finland
Central Finland Central Hospital
Jyväskylä, , Finland
Kuopio University Hospital
Kuopio, , Finland
Oulu University Hospital
Oulu, , Finland
Satakunta Central Hospital
Pori, , Finland
Hatanpää Hospital
Tampere, , Finland
Tampere University Hospital
Tampere, , Finland
Turku University Hospital
Turku, , Finland
Vaasa Central Hospital
Vaasa, , Finland
Sørlandet sykehus HF
Arendal, , Norway
Oslo University Hospital, Ullevål Hospital
Oslo, , Norway
Martina Hansens Hospital
Sandvika, , Norway
St. Olafs Hospital HF
Trondheim, , Norway
Skånevård Sund, Region Skåne
Helsingborg, , Sweden
Kalmar County Hospital
Kalmar, , Sweden
Linköping University Hospital
Linköping, , Sweden
Varberg Hospital
Varberg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ryosa A, Kukkonen J, Bjornsson Hallgren HC, Moosmayer S, Holmgren T, Ranebo M, Boe B, Aarimaa V; ACCURATE study group. Acute Cuff Tear Repair Trial (ACCURATE): protocol for a multicentre, randomised, placebo-controlled trial on the efficacy of arthroscopic rotator cuff repair. BMJ Open. 2019 May 19;9(5):e025022. doi: 10.1136/bmjopen-2018-025022.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ACCURATE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.